세계의 단일세포 시퀀싱 시장 : 시스템 유형별, 최종 사용자별, 응용 분야별, 주요 지역별 업계 동향과 예측

Single Cell Sequencing Market: Overview

As per Roots Analysis, the single cell sequencing market is estimated to grow from USD 1,387 million in the current year and is anticipated to grow at a CAGR of 15% during the forecast period, till 2035.

Single Cell Sequencing Services and Technologies Market: Overview

The market sizing and opportunity analysis has been segmented across the following parameters:

Market Segment

• Services
• Technologies

Type of System

• Sequencing
• Workflow Instruments

End-user

• Academics and Research Institutes
• Pharmaceutical Companies
• Other End-users

Area of Application

• Diagnostics
• Drug Discovery
• Precision Medicine

Key Geographies

• North America
• Europe
• Asia-Pacific
• Rest of the World

Single Cell Sequencing market: Growth and Trends

Over the years, advancements in technology within genomics have allowed pharmaceutical companies to pursue a more individualized and focused method for developing drugs and therapies. In particular, next-generation sequencing (NGS) technologies have made it possible to sequence millions of human genomes from various backgrounds. The significant amount of blockchain in genomic data management from the previously mentioned sequencing studies have produced important insights into individuals' probable reactions to various treatment protocols. Advancements in this area have made NGS technologies more cost-effective and widely available. The price of sequencing one genome has decreased from approximately USD 3 billion (Human Genome Project 1990) to USD 1,000 (Illumina sequencing kits) in the past twenty years. Nonetheless, NGS-based analyses are restricted to providing adequate information on gene expression. This method cannot quantify nucleic acid content within individual cells, thus failing to provide gene expression data at single cell resolution. Enhanced molecular probing solutions are needed to gain a deeper insight into how individual cells interact with their microenvironment. In this setting, high-throughput single cell analysis, a novel analytical method, is regarded as an effective approach for examining individual cells, allowing scientists to investigate gene expression at the resolution of single cells.

Single cell technologies provide numerous benefits compared to conventional genomic analyses, allowing for the identification of intricate and infrequent cell populations, while clarifying developmental pathways of unique cell lineages. Although single cell technologies have the potential for various applications in biotechnology and medical research, they remain confined to preliminary research endeavors. This is mainly due to specific difficulties linked to data processing and quality management. Additionally, the absence of flexibility in silico tools is viewed as one of the key obstacles to effective analysis and interpretation of single cell sequencing data. Moreover, the steady expenses of process execution and related labor-intensive protocols present additional obstacles to embracing single cell sequencing technology. The launch of the RNA-QC-Chain tool (aimed at tackling issues related to data processing and quality control) and the Human Cell Atlas initiative (which focuses on creating the first entire transcriptome map of human cells) are viewed as significant milestones in single cell genomics.onsidering the capability of single cell RNA sequencing (scRNA-seq) technologies to explore previously unclear cellular processes and discover new biomarkers / therapeutic targets, they are expected to experience considerable market growth and acceptance in biomedical research throughout the forecast period.

Single Cell Sequencing Services and Technologies Market: Key Insights

The report delves into the current state of the single cell sequencing services and technologies market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, close to 100 players claim to offer single cell sequencing services using a variety of unique technology platforms across the globe.

• The current market landscape is characterized by the presence of several non-industry players based in developed regions; quite recently, some industry players have entered this upcoming segment of the industry.
• Technology providers are steadily enhancing their respective product portfolios in order to achieve a competitive edge in the industry.
• Over the years, the intellectual capital related to single cell sequencing systems has grown at a commendable pace; majority of the patents have been filed in North America.

• Several organizations, having realized the untapped potential within this emerging segment, have awarded grants worth ~USD 1 billion, across 2,300+ instances in the period since 2016.
• The growing interest is also reflected by the surge of activity witnessed in this field, in form of capital investments, partnership agreements and product launches.
• Given the rising demand for single cell genomic data, and anticipated introduction of advanced sequencing technologies, the market is poised to grow at an annualized rate of ~17% over the next decade.

• The projected opportunity within the single cell sequencing market is expected to be well distributed within different areas of application and end users, across the globe.

Single Cell Sequencing Market: Key Segments

Sequencing Systems are Likely to Capture Majority of the Current Single-cell Sequencing Market Share

In terms of type of instrument, the single-cell sequencing market is segmented across various instruments such as workflow and sequencing instruments. In the current year, majority of the market share is captured by sequencing instruments (around 51%). However, the workflow segment is likely to grow at a higher CAGR of 34% during the forecast period.

Currently, Academic and Research Institutions Capture the Highest Singe Cell Sequencing Market Share

In terms of end-users, the single-cell sequencing market is segmented across academic and research institutions, pharmaceutical companies and other end-users. Most of the current market share is captured by academic and research institutions (around 60%), followed by pharmaceutical companies (30%). The trend is likely to similar in the coming years.

At present, Academic and Research Institutions Capture the Highest Single Cell Sequencing Market Share

In terms of end-users, the single-cell sequencing market is segmented across academic and research institutions, pharmaceutical companies and other end-users. Most of the current market share is captured by academic and research institutions (around 60%), followed by pharmaceutical companies (30%). The trend is likely to similar in the coming years.

Drug Discovery Segment is Likely to Capture the Highest Singe Cell Sequencing Market Share in the Future

In terms of area of application, the single-cell sequencing market is segmented across drug discovery, diagnostics, precision medicine and others. Around 50% of the market share is likely to be captured by drug discovery segment, followed by diagnostics (20%) and precision medicine (17%).

North America is Likely to Propel the Single-cell Sequencing Market

In terms of geographical regions, the single-cell sequencing market is segmented across North America, Europe, Asia-Pacific and Rest of the World. Around 50% of the market share is likely to be captured by North America, followed by Europe (26%) and Asia-Pacific (24%).

Example Players in Single cell Sequencing Market

• Active Motif
• Admera Health
• Annoroad Genomics
• BGI Genomics
• CD Genomics
• MedGenome
• Quick Biology
• SingulOmics
• 10x Genomics
• Cell Microsystems
• Fluidigm
• Illumina
• Mission Bio
• Oxford Nanopore Technologies

Single Cell Services and Technologies Market: Research Coverage

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the single cell sequencing market, focusing on key market segments, including [A] market segments, [B] type of system, [C] end-user, [D] area of application, and [E] key geographical regions.
• Market Landscape: A detailed assessment of overall competitive landscape of single cell sequencing workflow instruments based on several relevant parameters, such as [A] target nucleic acid, [B] type of application, [C] type of application, [D] year of establishment, [E] company size and [F] geographical location.
• Company Competitiveness Analysis: A comprehensive competitive analysis of single cell technologies examining factors, such as supplier power and other important technology related specifications, such as maximum sequencing output, maximum reads per run, maximum read length, quality score, applications and cost of sequencer.
• Company Profiles: In-depth profiles of single cell companies that are engaged in offering single cell sequencing services and single cell technologies, based on several parameters such as [A] year of establishment, [B] location of headquarters, [C] proprietary technology platforms, [D] recent developments and [E] an informed future outlook.
• Patent Analysis: An insightful analysis of the various patents that have been filed / granted for single cell sequencing technologies, based on parameters, such as [A] patent type, [B] publication year, [C] geographical location, [D] Cooperative Patent Classification (CPC) symbols, [E] emerging focus areas, and [F] type of applicant.
• Grants Analysis: A detailed analysis of the grants that have been awarded to research institutes engaged in projects related to single cell sequencing, based on multiple parameters, such as [A] year of grant award, [B] grant amount, [C] focus area, [D] activity code, [E] support period, [F] funding mechanism, [G] funding institute center, [H] type of recipient organization, [I] popular recipient organizations and [J] prominent program officers.
• Recent Developments: An insightful analysis of the recent developments / trends in the related to single cell sequencing, offering insights on [A] partnerships and collaborations established within the industry, [B] funding and investments, and [C] recent product launches related to single cell sequencing.

Key Questions Answered in this Report

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What is the current global capacity of developers?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research and Methodology
• 1.3. Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Overview of Single cell Sequencing
  • 3.2.1. Comparison of Bulk RNA and Single cell RNA Sequencing
• 3.3. Applications of Single cell Sequencing
  • 3.3.1. In Cancer Research
  • 3.3.2. In Clinical Diagnostics
  • 3.3.3. In Drug Discovery
  • 3.3.4. In Embryology
  • 3.3.5. In Immunology
  • 3.3.6. In Microbiology
  • 3.3.7. In Neurology
  • 3.3.8. In Organ Development
• 3.4. Challenges Associated with Single cell Sequencing
  • 3.4.1. Data Pre-processing
  • 3.4.2. Low Capturing Efficiency
  • 3.4.3. Rigid and Undefined Statistical Frameworks
  • 3.4.4. Lack of Appropriate Quality Control Systems
• 3.5. Future Perspectives

4. MARKET LANDSCAPE: SINGLE CELL SEQUENCING SERVICE PROVIDERS

• 4.1. Chapter Overview
• 4.2. Single cell Sequencing Service Providers: Market Landscape of Industry Players
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Location of Headquarters
  • 4.2.4. Analysis by Sequencing Method Used
  • 4.2.5. Analysis by Type of Service Offered
  • 4.2.6. Analysis by Type of Library Preparation System Used
  • 4.2.7. Analysis by Type of Sequencing System Used
• 4.3. Single cell Sequencing Service Providers: Market Landscape of Non-Industry Players
  • 4.3.1. Analysis by Location of Organization
  • 4.3.2. Analysis by Sequencing Method Used
  • 4.3.3. Analysis by Type of Service Offered
  • 4.3.4. Analysis by Type of Library Preparation System Used
  • 4.3.5. Analysis by Type of Sequencing System Used

5. MARKET LANDSCAPE: SINGLE CELL SEQUENCING TECHNOLOGY PROVIDERS

• 5.1. Chapter Overview
• 5.2. Single cell Sequencing Systems and Technologies: Market Landscape of Workflow Instruments
  • 5.2.1. Analysis by Target Nucleic Acid
  • 5.2.2. Analysis by Type of Application
  • 5.2.3. Analysis by Throughput
• 5.3. Single cell Sequencing Systems and Technologies: Developer Landscape
  • 5.3.4. Analysis by Year of Establishment
  • 5.3.5. Analysis by Company Size
  • 5.3.6. Analysis by Location of Headquarters
• 5.4. Single cell Sequencing Systems and Technologies: Market Landscape of Sequencing Instruments
  • 5.4.1. Analysis by Type of Application
  • 5.4.2. Analysis by Maximum Output
  • 5.4.3. Analysis by Maximum Read Length
  • 5.4.4. Analysis by System Efficiency
  • 5.4.5. Analysis by Sequencing Chemistry
• 5.5. Single cell Sequencing Systems and Technologies: Developer Landscape
  • 5.5.6. Analysis by Year of Establishment
  • 5.5.7. Analysis by Company Size
  • 5.5.8. Analysis by Location of Headquarters

6. SINGLE CELL SEQUENCING TECHNOLOGIES: COMPETITIVENESS ANALYSIS

• 6.1. Chapter Overview
• 6.2. Key Parameters and Methodology
• 6.3. Competitiveness Analysis: Single cell Workflow Instruments
• 6.4. Competitiveness Analysis: Single cell Sequencing Instruments

7. COMPANY PROFILES: SINGLE CELL SEQUENCING SERVICE PROVIDERS

• 7.1. Chapter Overview
• 7.2. Active Motif
  • 7.2.1. Company Overview
  • 7.2.2. Recent Developments and Future Outlook
• 7.3. Admera Health
  • 7.3.1. Company Overview
  • 7.3.2. Recent Developments and Future Outlook
• 7.4. Annoroad Genomics
  • 7.4.1. Company Overview
  • 7.4.2. Recent Developments and Future Outlook
• 7.5. BGI Genomics
  • 7.5.1. Company Overview
  • 7.5.2. Recent Developments and Future Outlook
• 7.6. CD Genomics
  • 7.6.1. Company Overview
  • 7.6.2. Recent Developments and Future Outlook
• 7.7. MedGenome
  • 7.7.1. Company Overview
  • 7.7.2. Recent Developments and Future Outlook
• 7.8. Quick Biology
  • 7.8.1. Company Overview
  • 7.8.2. Recent Developments and Future Outlook
• 7.9. SingulOmics
  • 7.9.1. Company Overview
  • 7.9.2. Recent Developments and Future Outlook

8. COMPANY PROFILES: SINGLE CELL SEQUENCING TECHNOLOGY PROVIDERS

• 8.1. 10x Genomics
  • 8.1.1. Company Overview
  • 8.1.2. Financial Information
  • 8.1.3. Product Portfolio
    • 8.1.3.1. 10x Chromium
  • 8.1.4. Recent Developments and Future Outlook
• 8.2. Cell Microsystems
  • 8.2.1. Company Overview
  • 8.2.2. Product Portfolio
    • 8.2.2.1. Cellraft AIR
• 8.3. Fluidigm
  • 8.3.1. Company Overview
  • 8.3.2. Financial information
  • 8.3.3. Product Portfolio
    • 8.3.3.1. Fluidigm C1
  • 8.3.4. Recent Developments and Future Outlook
• 8.4. Illumina
  • 8.4.2. Financial Information
  • 8.4.3. Product Portfolio
    • 8.4.3.1. MiSeq Series
    • 8.4.3.2. Nextseq Series
    • 8.4.3.3. NovaSeq 6000 System
  • 8.4.4. Recent Developments and Future Outlook
• 8.5. Mission Bio
  • 8.5.1. Company Overview
  • 8.5.2. Product Portfolio
    • 8.5.2.1. Tapestri
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. Oxford Nanopore Technologies
  • 8.6.1. Company Overview
  • 8.6.2. Financial Information
  • 8.6.3. Product Portfolio
    • 8.6.3.1. MinIon Systems
    • 8.6.3.2. PromethIon Systems
  • 8.6.4. Recent Developments and Future Outlook

9. PATENT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Scope and Methodology
• 9.3. Single cell Sequencing: Patent Analysis
  • 9.3.1. Analysis by Publication Year
  • 9.3.2. Analysis by Geographical Location
  • 9.3.3. Analysis by CPC Symbols
  • 9.3.4. Word Cloud: Emerging Focus Areas
  • 9.3.5. Analysis by Type of Applicant
  • 9.3.6. Leading Players: Analysis by Number of Patents
• 9.4. Single cell Sequencing: Benchmarking Analysis
  • 9.4.1. Analysis by Patent Characteristics
  • 9.4.2. Analysis by Geography
• 9.5. Single cell Sequencing: Patent Valuation Analysis

10. ACADEMIC GRANT ANALYSIS

• 10.1. Chapter Overview
• 10.2. Scope and Methodology
• 10.3. Single cell Sequencing: Analysis of Academic Grants
  • 10.3.1. Analysis by Year of Grant Award
  • 10.3.2. Analysis by Grant Amount
  • 10.3.3. Analysis by Focus Area
  • 10.3.4. Analysis by Activity Code
  • 10.3.5. Analysis by Support Period
  • 10.3.6. Analysis by Funding Mechanism
  • 10.3.7. Analysis by Funding Institute Center
  • 10.3.8. Analysis by Type of Recipient Organization
  • 10.3.9. Popular Recipient Organizations: Analysis by Number of Grants
  • 10.3.10. Prominent Program Officers: Analysis by Number of Grants

11. RECENT DEVELOPMENTS: SINGLE CELL SEQUENCING MARKET

• 11.1. Chapter Overview
• 11.2. Single cell Sequencing: Recent Partnerships
  • 11.2.1. Partnership Models
  • 11.2.2. Analysis by Year of Partnership
  • 11.2.3. Analysis by Type of Agreement
  • 11.2.4. Analysis by Focus Area of Partnership
  • 11.2.5. Regional Analysis by Number of Partnerships
• 11.3. Single cell Sequencing: Recent Funding and Investments
  • 11.3.1. Analysis by Year of Funding
  • 11.3.3. Analysis by Type of Funding
  • 11.3.2. Analysis by Amount Invested
  • 11.3.4. Most Active Players: Analysis by Amount Invested
  • 11.3.5. Most Active Investors: Analysis by Number of Funding Instances
• 11.4. Single cell Sequencing: Recent Product Launches
  • 11.4.1. Analysis by Year of Product Launch
  • 11.4.2. Analysis by Type of Product
  • 11.4.3. Analysis by Focus Area
  • 11.4.4. Most Active Players: Analysis by Number of Launches

12. MARKET SIZING AND OPPORTUNITY ANALYSIS

• 12.1. Chapter Overview
• 12.2. Key Assumptions and Forecast Methodology
• 12.3. Overall Single cell Sequencing Services and Technologies Market Opportunity,
• 12.4. Single cell Sequencing Services and Technologies Market Opportunity Across Key Market Segments, Till 2030
• 12.5. Single cell Sequencing Services and Technologies Market Opportunity:
• 12.6. Single cell Sequencing Services and Technologies Market Opportunity: Distribution by End-User 2020 and 2030
• 12.7. Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Area of Application, 2020 and 2030
• 12.8. Single cell Sequencing Services and Technologies Market Opportunity: Geographical Distribution, 2020 and 2030
  • 12.8.1. Single cell Sequencing Services and Technologies Market Opportunity in North America, Till 2030
    • 12.8.1.1. Single cell Sequencing Services and Technologies Market Opportunity in North America Across Key Market Segments, Till 2030
      • 12.8.1.1.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Service Providers, Till 2030
      • 12.8.1.1.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Technology Providers, Till 2030
    • 12.8.1.2. Single cell Sequencing Services and Technologies Market Opportunity in North America: Distribution by End-Users, Till 2030
      • 12.8.1.2.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Academic and Research Institutions, Till 2030
      • 12.8.1.2.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Pharmaceutical Companies, Till 2030
      • 12.8.1.2.3. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other End-Users, Till 2030
    • 12.8.1.3. Single cell Sequencing Services and Technologies Market Opportunity in North America: Distribution by Area of Application, Till 2030
      • 12.8.1.3.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Diagnostics, Till 2030
      • 12.8.1.3.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Drug Discovery, Till 2030
      • 12.8.1.3.3. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Precision Medicine, Till 2030
      • 12.8.1.3.4. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other Applications, Till 2030
  • 12.8.2. Single cell Sequencing Services and Technologies Market Opportunity in Europe, Till 2030
    • 12.8.2.1. Single cell Sequencing Services and Technologies Market Opportunity in Europe Across Key Market Segments, Till 2030
      • 12.8.2.1.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Service Providers, Till 2030
      • 12.8.2.1.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Technology Providers, Till 2030
    • 12.8.2.2. Single cell Sequencing Services and Technologies Market Opportunity in Europe: Distribution by End-Users, Till 2030
      • 12.8.2.2.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Academic and Research Institutions, Till 2030
      • 12.8.2.2.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Pharmaceutical Companies, Till 2030
      • 12.8.2.2.3. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other End-Users, Till 2030
    • 12.8.2.3. Single cell Sequencing Services and Technologies Market Opportunity in Europe: Distribution by Area of Application, Till 2030
      • 12.8.2.3.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Diagnostics, Till 2030
      • 12.8.2.3.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Drug Discovery, Till 2030
      • 12.8.2.3.3. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Precision Medicine, Till 2030
      • 12.8.2.3.4. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other Applications, Till 2030
  • 12.8.3. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific, Till 2030
    • 12.8.3.1. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific Across Key Market Segments, Till 2030
      • 12.8.3.1.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Service Providers, Till 2030
      • 12.8.3.1.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Technology Providers, Till 2030
    • 12.8.3.2. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Distribution by End-Users, Till 2030
      • 12.8.3.2.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Academic and Research Institutions, Till 2030
      • 12.8.3.2.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Pharmaceutical Companies, Till 2030
      • 12.8.3.2.3. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other End-Users, Till 2030
    • 12.8.3.3. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Distribution by Area of Application, Till 2030
      • 12.8.3.3.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Diagnostics, Till 2030
      • 12.8.3.3.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Drug Discovery, Till 2030
      • 12.8.3.3.3. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Precision Medicine, Till 2030
      • 12.8.3.3.4. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other Applications, Till 2030
  • 12.8.4. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World, Till 2030
    • 12.8.4.1. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World Across Key Market Segments, Till 2030
      • 12.8.4.1.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Service Providers, Till 2030
      • 12.8.4.1.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Technology Providers, Till 2030
    • 12.8.4.2. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Distribution by End-Users, Till 2030
      • 12.8.4.2.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Academic and Research Institutions, Till 2030
      • 12.8.4.2.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Pharmaceutical Companies, Till 2030
      • 12.8.4.2.3. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other End-Users, Till 2030
    • 12.8.4.3. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Distribution by Area of Application, Till 2030
      • 12.8.4.3.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Diagnostics, Till 2030
      • 12.8.4.3.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Drug Discovery, Till 2030
      • 12.8.4.3.3. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Precision Medicine, Till 2030
      • 12.8.4.3.4. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other Applications, Till 2030

13. CONCLUSION

• 13.1. Chapter Overview
• 13.2. Key Takeaways

14. EXECUTIVE INSIGHTS

15. APPENDIX I: TABULATED DATA